VQ Biomedical a medical technology company developing an innovative oxygenation catheter for treating acute respiratory distress syndrome.
VQ Biomedical has raised $2.4M in total funding. The most recent round was Grant. The last funding was announced in March 2025.
VQ Biomedical's investors include DARPA, Harbright Ventures, Duke Capital Partners, Wolfpack Investor Network.
VQ Biomedical is headquartered in Apex, United States.
VQ Biomedical a medical technology company developing an innovative oxygenation catheter for treating acute respiratory distress syndrome.
VQ Biomedical is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VQ Biomedical — Funding & Investors." VCBacked, March 27, 2025, https://www.vcbacked.co/company/vq-biomedical. Accessed October 27, 2026.
VCBacked. (2025). VQ Biomedical — Funding & Investors. Retrieved October 27, 2026, from https://www.vcbacked.co/company/vq-biomedical
{{cite web |title=VQ Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/vq-biomedical |website=VCBacked |access-date=October 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated